Pharmacological properties of naturally occurring variants of the human norepinephrine transporter

Pharmacogenetics

Volumn 10, Issue 5, 2000, Pages 397-405

  Runkel, Fabian ^b   Brüss, Michael ^b   Nöthen, Markus M ^b   Stöber, Gerald ^b   Propping, Peter ^b   Bönisch, Heinz ^a  

^a UNIVERSITY OF BONN   (Germany)

^b NONE

Author keywords

Desipramine; HNET; Human norepinephrine transporter variants; Norepinephrine transport kinetics

Indexed keywords

CARRIER PROTEIN; DESIPRAMINE; GLYCINE; NORADRENALIN; NORADRENALIN TRANSPORTER; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG POTENCY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RAT; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION; SYNAPTOSOME;

AMINO ACID SUBSTITUTION; ANIMALS; CARRIER PROTEINS; COS CELLS; DESIPRAMINE; HUMANS; MUTAGENESIS, SITE-DIRECTED; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PROTEIN ISOFORMS; SYMPORTERS; TRANSFECTION; TRITIUM;

EID: 0008320370     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200007000-00003     Document Type: Article

References (54)

1. Amara SG, Kuhar MJ. Neurotransmitter transporters. Recent progress. Annu Rev Neurosci 1993; 16:73-93.
2. Apparsundaram S, Moore KR, Malone MD, Hartzell HC, Blakely RD. Molecular cloning of an L-epinephrine transporter from sympathetic ganglia of the bullfrog. Rana catesbia. J Neurosci 1997; 17:2691-2702.
3. Barker EL, Blakely RD. Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter. Mol Pharmacol 1996; 50:957-965.
4. Bönisch H. Transport and drug binding kinetics in membrane vesicle preparation. In: Amara SG, editor. Neurotransmitter transporters. Methods in enzymology, vol. 296. New York: Plenum Press; 1998, pp. 259-278.
5. Bönisch H. Brüss M. The noradrenaline transporter of the neuronal plasma membrane. Ann NY Acad Sci 1994; 733:193-202.
6. Bönisch H, Hammermann R, Brüss M. Role of protein kinase C and second messengers in regulation of the norepinephrine transporter. Adv Pharmacol 1997; 42:185-186.
7. Borowsky B, Hoffman BJ. Neurotransmitter transporters: molecular biology, function, and regulation. Int Rev Neurobiol 1995; 38:139-199.
8. Brüss M, Kunz J, Lingen B, Bönisch H. Chromosomal mapping of the human gene for the tricyclic antidepressant-sensitive noradrenaline transporter. Hum Genet 1991; 91:278-280.
9. Brüss M, Hammermann R, Bönisch H. Antipeptide antibodies confirm the topology of the human norepinephrine transporter. J Biol Chem 1995; 270:9197-9192.
10. Brüss M, Pörzgen P, Bryan-Lluka LJ, Bönisch H. The rat norepinephrine transporter: molecular cloning from PC12 cells and functional expression. Mol Brain Res 1997; 52:257-262.
11. Brüss M, Wieland A, Bönisch H. Molecular cloning and functional expression of the mouse dopamine transporter. J Neural Transm 1999; 106:657-662.
12. Chang AS, Chang SM, Starnes DM, Schroeter S, Bauman AL, Blakely RD. Cloning and expression of the mouse serotonin transporter. Mol Brain Res 1996; 43:185-192.
13. Chen C, Okahama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987; 7, 2745-2752.
14. Chen J-G, Sachpatzidis A, Rudnick G. The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding. J Biol Chem 1997; 272:28321-28327.
15. 50) of an enzymatic reaction. Biochem Pharmacol 1973; 22:3099-3108.
16. Cohen MD, Finberg J, Dibner-Dunlap M, Yuih SN, Thames MD. Effects of desipramine hydrochloride on peripheral sympathetic nerve activity. Am J Physiol 1990; 258.-R876-R882.
17. Danek Burgess KS, Justice JB Jr. Effects of serine mutations in transmembrane domain 7 of the human norepinephrine transporter on substrate binding and transport. J Neurochem 1999; 73:656-664.
18. Eisenhofer G, Goldstein DS, Kopin IJ. Plasma dihydroxyphenylglycol for estimation od noradrenaline neuronal re-uptake in the sympathetic nervous system in vivo. Clin Sci 1989; 76:171-182.
19. Eisenhofer G, Esler MD, Meredith IT, Ferrier C, Lambert G, Jennings G. Neuronal re-uptake of noradrenaline by sympathetic nerves in humans. Clin Sci 1991a; 80:257-263.
20. Eisenhofer G, Saigusa T, Esler MD, Cox HS, Angus JA, Dorward PK. Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits. Am J Physiol 1991b; 260:R824-R832.
21. Esler M, Jackman G, Leonard P, Skews H, Bobik A, Korner P. Effect of norepinephrine uptake blockers on norepinephrine kinetics. Clin Pharmacol Ther 1981; 29:12-20.
22. Esler M, Turbott J, Schwarz R, Leonard P, Bobik A, Skews H, Jackman G. The peripheral kinetics of norepinephrine in depressive illness. Arch Gen Psychiatry 1982; 39:295-300.
23. Esler MD, Wallin G, Dorward PK, Eisenhofer G, Westerman R, Meredith I, et al. Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. Am J Physiol 1991; 260:R817-R823.
24. Friedgen B, Wölfel R, Russ H, Schömig E, Graefe KH. The role of extraneuronal amine transport systems for the removal of extracellular catecholamines in the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 1996; 354:275-286.
25. Fritz JD, Jayanthi LD, Thoreson MA, Blakely RD. Cloning and chromosomal mapping of the murine norepinephrine transporter. J Neurochem 1998; 70:2241-2251.
26. Giros B, Wang Y-M, Suter S, McLeskey SB, Pifl C, Caron MG. Delineation of discrete domains for substrate, cocaine and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J Biol Chem 1994; 269:15985-15988.
27. Graefe KH, Bönisch H. The transport of amines across the axonal membranes of noradrenergic and dopaminergic neurones. In: Trendelenburg U, Weiner N, editors. Catecholamines I: handbook of experimental pharmacology, vol. 90/I. New York: Springer-Verlag: 1988, pp. 193-245.
28. Kilty JE, Lorang D, Amara SG. Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 1991; 254:578-579.
29. Kitayama S, Shimada S, Xu H, Markham L, Donovan D, Uhl GR. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc Natl Acad Sci USA 1992; 89:7782-7785.
30. Kopin IJ. Plasma levels of catecholamines and dopamine-ß-hydroxylase. In: Trendelenburg U, Weiner N, editors. Catecholamines II: handbook of experimental pharmacology, vol. 90/ II. New York: Springer-Verlag: 1989, pp. 211-275.
31. Kurose M, Okumura K, Ogawa H, Yoshimura M, Morita E, Yasue H. Reduced cardiac extraction of norepinephrine and epinephrine in patients with heart failure - correlation with left ventricular function. Int J Cardiol 1994; 47:21-29.
32. Lesch KP, Wolozin BL, Murphy DL, Riederer P. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem 1993; 60:2319-2322.
33. Lingen B, Brüss M, Bönisch H. Cloning and expression of the bovine sodium-and chloride-dependent noradrenaline transporter. FEBS Lett 1994; 342:235-238.
34. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
35. Ludwig J, Gerlich M, Halbrügge T, Graefe KH. The synaptic noradrenaline concentration in humans as estimated from simultaneous measurements of plasma noradrenaline and dihydroxyphenylglycol (DOPEG). J Neural Transm 1990; 32:441-445.
36. Ludwig J, Gerlich M, Halbrügge T, Graefe KH. Plasma norepinephrine and dihydroxyphenylglycol in essential hypertension. Hypertension 1991; 17:546-552.
37. Ludwig J, Halbrügge T, Gerlich M, Graefe KH. Estimation of noradrenaline concentration in the axoplasm of noradrenergic neurones in man. Clin Auton Res 1992; 2, 159-164.
38. Mayser W, Betz H, Schloss P. Isolation of cDNAs encoding a novel member of the neurotransmitter transporter gene family. FEBS Lett 1991; 295:203-206.
39. Merlet P, Dubois-Rande JL, Adnot S, Bourguignon MH, Benvenuti C, Loisance D, et al. Myocyrdial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol 1992; 19:10-16.
40. Merlet P, Pouillart F, Dubois-Rande JL, Delahaye N, Fumey R, Castaigne A, Syrota A. Sympathetic nerve alterations assessed with 1231-MIBG in the failing human heart. J Nucl Med 1999; 40:224-231.
41. Mortensen OV, Kristensen AS, Rudnick G, Wiborg O. Molecular cloning, expression and characterization of a bovine scrotonin transporter. Brain Res Mol Brain Res 1999; 71:120-126.
42. Pacholczyk T, Blakely RD, Amara SG. Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter. Nature 1991; 350:350-354.
43. Paczkowski FA, Bryan-Lluka LJ, Pörzgen P, Brüss M, Bönisch H. Comparison of the pharmacological properties of cloned rat, human, and bovine norepinephrine transporters. J Pharmaco/ Exp Ther 1999; 290:761-767.
44. Pliszka SR, Maas JW, Javors MA, Rogeness GA, Baker J. Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 1994; 33:1165-1173.
45. Pörzgen P, Bönisch B, Brüss M. Molecular cloning and organization of the coding region of the human norepinephrine transporter gene. Biochem Biophys Res Commun 1995; 215:1145-1150.
46. 2 receptors. Brain Res Mol Brain Res 1994; 27:337-341.
47. Stöber G, Nöthen MM, Pörzgen P, Brüss M, Bönisch H, Knapp M, et al. Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am J Med Gen 1996; 67:523-532.
48. Stöber G, Hebebrand J, Cichon S, Brüss M, Bönisch H, Lehmkuhl G, et al. Tourette syndrome and the norepinephrine transporter gene: results of a systematic mutation screening. Am J Med Gen 1999; 88:158-163.
49. Szabo B, Schultheiss A, Starke K. The noradrenaline uptake inhibitor (+)-oxaprotiline, but not the inactive enantiomer (-)-oxaprotiline, inhibits sympathetic nerve activity in the rabbit: involvement of adrenoceptors. Eur J Pharmacol 1991; 199:325-334.
50. Usdin TB, Mezey E, Chen C, Brownstein MJ, Hoffman BJ. Cloning of the cocaine-sensitive bovine dopamine transporter. Proc Natl Acad Sci USA 1991; 88:11168-11171.
51. Vandenbergh DJ, Persico AM, Uhl GR. A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetetive element and provides racially dimorphic TaqI RFLPs. Brain Res Mol Brain Res 1992; 15:161-166.
52. Vrana KE, Walker SJ, Rucker P, Liu X. A carboxyl terminal leucine zipper is required for tyrosine hydroxylase tetramer formation. J Neurochem 1994; 63:2014-2020.
53. Wade PR, Chen J, Jaffe B, Kassem IS, Blakely RD, Gershon MD. Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J Neurosci 1996; 16:2352-2364.
54. Yatham LN, Sacamano J, Kusumakar V. Assessment of noradrenergic functioning in patients with non-combat-related post traumatic stress disorder: a study with desmethylimipramine and orthostatic challenges. Psychiatry Res 1996; 63:1-6.